Citation: R. Laucirica et Mr. Schwartz, Clinical utility of flow cytometry in body fluid cytology: To flow or not to flow? That is the question, DIAGN CYTOP, 24(5), 2001, pp. 305-306
Authors:
Zahnow, CA
Cardiff, RD
Laucirica, R
Medina, D
Rosen, JM
Citation: Ca. Zahnow et al., A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation, CANCER RES, 61(1), 2001, pp. 261-269
Authors:
Ostrowski, ML
Pindur, J
Laucirica, R
Chakraborty, S
Ramzy, I
Citation: Ml. Ostrowski et al., Proliferative activity in invasive breast carcinoma - A comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to imageanalytic, flow cytometric and histologic parameters, ACT CYTOL, 45(6), 2001, pp. 965-972
Authors:
Li, ML
Lewis, B
Capuco, AV
Laucirica, R
Furth, PA
Citation: Ml. Li et al., WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis, ONCOGENE, 19(8), 2000, pp. 1010-1019
Authors:
Jerry, DJ
Kittrell, FS
Kuperwasser, C
Laucirica, R
Dickinson, ES
Bonilla, PJ
Butel, JS
Medina, D
Citation: Dj. Jerry et al., A mammary-specific model demonstrates the role of the p53 tumor suppressorgene in tumor development, ONCOGENE, 19(8), 2000, pp. 1052-1058
Authors:
Hadsell, DL
Murphy, KL
Bonnette, SG
Reece, N
Laucirica, R
Rosen, JM
Citation: Dl. Hadsell et al., Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis, ONCOGENE, 19(7), 2000, pp. 889-898
Authors:
Shariat, SF
Weizer, AZ
Green, A
Laucirica, R
Frolov, A
Wheeler, TM
Lerner, SP
Citation: Sf. Shariat et al., Prognostic value of p55 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder, UROLOGY, 56(5), 2000, pp. 735-740
Authors:
Kuperwasser, C
Hurlbut, GD
Kittrell, FS
Dickinson, ES
Laucirica, R
Medina, D
Naber, SP
Jerry, DJ
Citation: C. Kuperwasser et al., Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice - A model for Li-Fraumeni syndrome, AM J PATH, 157(6), 2000, pp. 2151-2159
Authors:
Furth, PA
Bar-Peled, U
Li, ML
Lewis, A
Laucirica, R
Jager, R
Weiher, H
Russell, RG
Citation: Pa. Furth et al., Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model, ONCOGENE, 18(47), 1999, pp. 6589-6596